Judo Bio Launches With $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

BusinesswireOct 7 07:00 ET

Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?

BenzingaOct 6 13:13 ET

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Simply Wall StOct 4 13:32 ET

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Is Expected To Breakeven In The Near Future

Yahoo FinanceOct 3 10:00 ET

BridgeBio Granted Perform Rating at Oppenheimer on Market Challenges

Seeking AlphaOct 3 09:08 ET

A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $282 to $370

Moomoo NewsOct 1 09:00 ET · Ratings